INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
77,575,733
Total 13F shares
68,152,781
Share change
-4,293,600
Total reported value
$2,803,305,570
Put/Call ratio
8.9%
Price per share
$41.13
Number of holders
270
Value change
-$206,182,700
Number of buys
129
Number of sells
149

Institutional Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q2 2023

As of 30 Jun 2023, INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) was held by 270 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,152,781 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, Champlain Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., Clearbridge Investments, LLC, COOKE & BIELER LP, and STATE STREET CORP. This page lists 275 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.